Assignee
SYNAFFIX BV
NL·29 granted patents·27 pending applications·342 citations·filing 2014–2025
Top patents by PatentIndex Score
56 records- 0198US9504758B2Modified antibody, antibody-conjugate and process for the preparation thereofSYNAFFIX BV·Filed 2015·Granted Nov 29, 2016·65 cites·20 claims
- 0297US10266502B2Process for the cycloaddition of a halogenated 1,3-dipole compound with a (hetero)cycloalkyneSYNAFFIX BV·Filed 2015·Granted Apr 23, 2019·78 cites·15 claims
- 0397US10239807B2Fused cyclooctyne compounds and their use in metal-free click reactionsSYNAFFIX BV·Filed 2015·Granted Mar 26, 2019·57 cites·21 claims
- 0497US9222940B2Fused cyclooctyne compounds and their use in metal-free click reactionsSYNAFFIX BV·Filed 2014·Granted Dec 29, 2015·91 cites·27 claims
- 0592US9636421B2Sulfamide linker, conjugates thereof, and methods of preparationSYNAFFIX BV·Filed 2016·Granted May 2, 2017·14 cites·15 claims
- 0691US11338043B2Antibody-conjugates with improved therapeutic index for targeting HER2 tumours and method for improving therapeutic index of antibody-conjugatesSYNAFFIX BV·Filed 2017·Granted May 24, 2022·8 cites·10 claims
- 0790US10072096B2Modified glycoprotein, protein-conjugate and process for the preparation thereofSYNAFFIX BV·Filed 2014·Granted Sep 11, 2018·9 cites·15 claims
- 0890US9988661B2Process for the modification of a glycoprotein using a glycosyltransferase that is or is derived from A β(1,4)-N-acetylgalactosaminyltransferaseSYNAFFIX BV·Filed 2016·Granted Jun 5, 2018·5 cites·11 claims
- 0990US2025084022A1Fused cyclooctyne compounds and their use in metal-free click reactionsSYNAFFIX BV·Filed 2024·Application pending·0 cites
- 1088US10792369B2Sulfamide linker, conjugates thereof, and methods of preparationSYNAFFIX BV·Filed 2017·Granted Oct 6, 2020·3 cites·25 claims
- 1186US11547763B2Enediyne conjugatesSYNAFFIX BV·Filed 2020·Granted Jan 10, 2023·3 cites·25 claims
- 1286US2025177554A1Modified antibody, antibody-conjugate and process for the preparation thereofSYNAFFIX BV·Filed 2024·Application pending·0 cites
- 1385US11850286B2Sulfamide linker, conjugates thereof, and methods of preparationSYNAFFIX BV·Filed 2020·Granted Dec 26, 2023·1 cites·28 claims
- 1484US11358921B2Fused cyclooctyne compounds and their use in metal-free click reactionsSYNAFFIX BV·Filed 2019·Granted Jun 14, 2022·1 cites·17 claims
- 1583US9987373B2Modified glycoprotein, protein-conjugate and process for the preparation thereofSYNAFFIX BV·Filed 2014·Granted Jun 5, 2018·3 cites·19 claims
- 1682US11299759B2Process for the modification of a glycoprotein using a glycosyltransferase that is or is derived from a β(1,4)-n-acetylgalactosaminyltransferaseSYNAFFIX BV·Filed 2018·Granted Apr 12, 2022·1 cites·9 claims
- 1779US11168085B2Process for the cycloaddition of a hetero(aryl) 1,3-dipole compound with a (hetero)cycloalkyneSYNAFFIX BV·Filed 2015·Granted Nov 9, 2021·2 cites·28 claims
- 1878US11951175B2Bioconjugates containing sulfamide linkers for use in treatmentSYNAFFIX BV·Filed 2017·Granted Apr 9, 2024·1 cites·21 claims
- 1976US12180145B2Fused cyclooctyne compounds and their use in metal-free click reactionsSYNAFFIX BV·Filed 2022·Granted Dec 31, 2024·0 cites·27 claims
- 2074US12049656B2Process for the modification of a glycoprotein using a glycosyltransferase that is or is derived from a β(1,4)-n-acetylgalactosaminyltransferaseSYNAFFIX BV·Filed 2022·Granted Jul 30, 2024·0 cites·14 claims
- 2174US2024398971A1Bioconjugates containing sulfamide linkers for use in treatmentSYNAFFIX BV·Filed 2024·Application pending·0 cites
- 2272US2025304611A1Synthesis of 6-azido-6-deoxy-2-n-acetyl-hexosamine-nucleoside diphosphateSYNAFFIX BV·Filed 2025·Application pending·0 cites
- 2371US12194107B2Modified antibody, antibody-conjugate and process for the preparation thereofSYNAFFIX BV·Filed 2020·Granted Jan 14, 2025·0 cites·22 claims
- 2470US2023127659A1Antibody-conjugates with improved therapeutic index for targeting her2 tumours and method for improving therapeutic index of antibody-conjugatesSYNAFFIX BV·Filed 2022·Application pending·0 cites
- 2568US12281135B2Synthesis of 6-azido-6-deoxy-2-n-acetyl-hexosamine-nucleoside diphosphateSYNAFFIX BV·Filed 2022·Granted Apr 22, 2025·0 cites·20 claims
- 2668US11713453B2Enzymes for trimming of glycoproteinsSYNAFFIX BV·Filed 2020·Granted Aug 1, 2023·0 cites·18 claims
- 2766US12084448B2Process for the cycloaddition of a (hetero)aryl 1,3-dipole compound with a (hetero)cycloalkyneSYNAFFIX BV·Filed 2021·Granted Sep 10, 2024·0 cites·18 claims
- 2865US12440573B2Antibody-conjugates for targeting of tumours expressing PTK7SYNAFFIX BV·Filed 2024·Granted Oct 14, 2025·0 cites·9 claims
- 2965US2023346965A1Enediyne conjugatesSYNAFFIX BV·Filed 2023·Application pending·0 cites
- 3065US2025090679A1Antibody-conjugates for targeting of tumours expressing trop-2SYNAFFIX BV·Filed 2024·Application pending·0 cites
- 3165US2023405143A1Tyrosine-based antibody conjugatesSYNAFFIX BV·Filed 2023·Application pending·0 cites
- 3263US2023338562A1Methods for the preparation of linker payload constructsSYNAFFIX BV·Filed 2022·Application pending·0 cites
- 3363US2023226208A1Methods for the preparation of bioconjugatesSYNAFFIX BV·Filed 2023·Application pending·0 cites
- 3462US11957763B2Sulfamide linkers for use in bioconjugatesSYNAFFIX BV·Filed 2020·Granted Apr 16, 2024·0 cites·20 claims
- 3561US2025082770A1Antibody-conjugates for targeting of tumours expressing carcinoembyronic antigenSYNAFFIX BV·Filed 2024·Application pending·0 cites
- 3661US2023190951A1Conjugates of antibodies an immune cell engagersSYNAFFIX BV·Filed 2022·Application pending·0 cites
- 3761US2023330245A1Antibody-exatecan conjugatesSYNAFFIX BV·Filed 2023·Application pending·0 cites
- 3860US11590239B2Antibody-conjugates with improved therapeutic index for targeting CD30 tumours and method for improving therapeutic index of antibody-conjugatesSYNAFFIX BV·Filed 2017·Granted Feb 28, 2023·0 cites·9 claims
- 3960US2023355791A1Glycan-conjugated antibodies binding to fc-gamma receptorSYNAFFIX BV·Filed 2023·Application pending·0 cites
- 4059US2023364262A1Via cycloaddition bilaterally functionalized antibodiesSYNAFFIX BV·Filed 2022·Application pending·0 cites
- 4159US2019225706A1Modified glycoprotein, protein-conjugate and process for the preparation thereofSYNAFFIX BV·Filed 2018·Application pending·0 cites
- 4259US2023114866A1Via cycloaddition bilaterally functionalized antibodiesSYNAFFIX BV·Filed 2022·Application pending·0 cites
- 4359US2025262314A1Multifunctional antibodiesSYNAFFIX BV·Filed 2022·Application pending·0 cites
- 4459US2025205353A1Antibody-conjugates for targeting of tumours expressing nectin-4SYNAFFIX BV·Filed 2023·Application pending·0 cites
- 4558US10874746B2Sulfamide linkers for use in bioconjugatesSYNAFFIX BV·Filed 2017·Granted Dec 29, 2020·0 cites·14 claims
- 4658US2022096652A1Acetal-based cleavable linkersSYNAFFIX BV·Filed 2021·Application pending·0 cites
- 4757US10858641B2Enzymes for trimming of glycoproteinsSYNAFFIX BV·Filed 2017·Granted Dec 8, 2020·0 cites·15 claims
- 4857US2025367315A1Antibody-drug conjugates with masked pbd dimersSYNAFFIX BV·Filed 2025·Application pending·0 cites
- 4954US12397063B2Antibody-conjugates for targeting of tumours expressing Trop-2SYNAFFIX BV·Filed 2021·Granted Aug 26, 2025·0 cites·21 claims
- 5054US2016235861A1Glycoengineered antibody, antibody-conjugate and methods for their preparationSYNAFFIX BV·Filed 2014·Application pending·0 cites
Showing the top 50 of 56 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →